FDA — authorised 13 July 1949
- Application: NDA006921
- Marketing authorisation holder: SCHERING
- Local brand name: CHLOR-TRIMETON
- Indication: SYRUP — ORAL
- Status: approved
🇺🇸 Chlor-Trimeton. in United States
FDA authorised Chlor-Trimeton. on 13 July 1949
Marketing authorisations
FDA — authorised 15 August 1950
- Application: NDA007638
- Marketing authorisation holder: BAYER HEALTHCARE LLC
- Local brand name: CHLOR-TRIMETON
- Indication: TABLET, EXTENDED RELEASE — ORAL
- Status: approved
FDA — authorised 31 March 1981
- Application: NDA018397
- Marketing authorisation holder: BAYER HEALTHCARE LLC
- Local brand name: CHLOR-TRIMETON
- Indication: TABLET, EXTENDED RELEASE — ORAL
- Status: approved
FDA — authorised 30 August 1982
- Application: NDA008794
- Marketing authorisation holder: SCHERING PLOUGH
- Local brand name: CHLOR-TRIMETON
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA
- Application: NDA008826
- Marketing authorisation holder: SCHERING PLOUGH
- Local brand name: CHLOR-TRIMETON
- Indication: INJECTABLE — INJECTION
- Status: approved
Frequently asked questions
Is Chlor-Trimeton. approved in United States?
Yes. FDA authorised it on 13 July 1949; FDA authorised it on 15 August 1950; FDA authorised it on 31 March 1981.
Who is the marketing authorisation holder for Chlor-Trimeton. in United States?
SCHERING holds the US marketing authorisation.